US
US Genomic Data Analysis Software Market Industry Trends and Forecast to 2034: Segmented by (Function, Deployment, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $1.17 Bn.
Canada at 17.1% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$3.04 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.01 Bn | — | — |
| 2025 (base) | $1.17 Bn | +$154.9 Mn | — |
| 2026 (forecast) | $1.35 Bn | +$178.5 Mn | +15.3% |
| 2027 (forecast) | $1.55 Bn | +$205.9 Mn | +32.9% |
| 2028 (forecast) | $1.79 Bn | +$237.4 Mn | +53.3% |
| 2029 (forecast) | $2.06 Bn | +$273.7 Mn | +76.7% |
| 2030 (forecast) | $2.38 Bn | +$315.5 Mn | +103.8% |
| 2031 (forecast) | $2.74 Bn | +$363.8 Mn | +135% |
| 2032 (forecast) | $3.16 Bn | +$419.5 Mn | +170.9% |
| 2033 (forecast) | $3.64 Bn | +$483.7 Mn | +212.3% |
| 2034 (forecast) | $4.20 Bn | +$557.7 Mn | +260.1% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$1.17 Bn
Canada
$229.8 Mn
China
$213.0 Mn
Japan
$150.8 Mn
Germany
$102.4 Mn
France
$78.2 Mn
Brazil
$73.2 Mn
Italy
$68.9 Mn
UK
$62.7 Mn
Ecuador
$55.5 Mn
Spain
$52.7 Mn
India
$51.2 Mn
Saudi Arabia
$45.4 Mn
Mexico
$36.5 Mn
Australia
$35.8 Mn
Russia
$30.0 Mn
New Zealand
$27.0 Mn
South Africa
$16.3 Mn
UAE
$15.9 Mn
Egypt
$6.8 Mn
Philippines
$6.4 Mn
Hong Kong
$5.1 Mn
Malaysia
$4.9 Mn
Singapore
$3.4 Mn
Thailand
$2.9 Mn
Kenya
$1.8 Mn
Genomic data analysis software turns raw DNA sequencing data into reports and insights for labs, doctors and researchers.
Key segments of the genomic Data Analysis Software market include function (Variant Calling, Interpretation and Reporting and Data Management) and deployment (Cloud and On-Premise).
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the genomic Data Analysis Software market.
Routine use of genomics in screening, pharmacy and primary care gives the genomic Data Analysis Software market large room to grow.
Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the genomic Data Analysis Software market.
The genomic Data Analysis Software market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the genomic Data Analysis Software market. Government digital health programs in US are speeding up adoption.
What doctors and scientists are doing in Genomic Data Analysis Software right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
Pharmaceuticals · US
Healthcare Services · US
Healthcare Services · US
Medical Devices · US
Medical Devices · US
Medical Devices · US